SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001485003-19-000066
Filing Date
2019-08-08
Accepted
2019-08-08 16:29:54
Documents
10
Period of Report
2019-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sesn-form8xk2q2109pr080820.htm 8-K 32046
2 EXHIBIT 99..1 sesenbio2q2019pressrelea.htm EX-99..1 26184
3 sesenbio2q2019pressrelea001.jpg GRAPHIC 221917
4 sesenbio2q2019pressrelea002.jpg GRAPHIC 192861
5 sesenbio2q2019pressrelea003.jpg GRAPHIC 232469
6 sesenbio2q2019pressrelea004.jpg GRAPHIC 216045
7 sesenbio2q2019pressrelea005.jpg GRAPHIC 251956
8 sesenbio2q2019pressrelea006.jpg GRAPHIC 191376
9 sesenbio2q2019pressrelea007.jpg GRAPHIC 81894
10 sesenbio2q2019pressrelea008.jpg GRAPHIC 62697
  Complete submission text file 0001485003-19-000066.txt   2058813
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 191010001
SIC: 2834 Pharmaceutical Preparations